This site is intended for healthcare professionals only
LoginRegister
Cohance Lifesciences announces USD 10 mn investment in cGMP Bioconjugation Suite at NJ BioLaurus Bio secures equity infusion of Rs 120 crore
KKR divests 5.8 percent stake in JB Chemicals & Pharma for Rs 1460 croreTeva to divest Teva-Takeda, its Business Venture in Japan
Bayer, Kumquat Biosciences ink pact to develop, commercialize KRAS G12D inhibitorGilead Sciences, Tubulis ink pact to develop ADC candidate for select solid tumor target
PfizerPfizer Gets CDSCO Panel Nod To Import 20 Valent Pneumococcal Conjugate Vaccine
Inclisiran be sold by retail under prescription of cardiologist only: CDSCO panel tells Novartis HealthcareInclisiran be sold by retail under prescription of cardiologist only: CDSCO panel tells Novartis...
Novartis concludes acquisition of Regulus TherapeuticsSuven Pharma to acquire controlling stake in NJ Bio with investment of USD 64.4 million
Carlyle to offload up to 10 percent stake in Piramal Pharma in Rs 26-27 billion deal: ReportPiramal Pharma to pay USD 407400 to resolve dispute with VetDC
AstraZeneca Imfinzi-based perioperative regimen approved in EU for resectable non-small cell lung cancerAstraZeneca Imfinzi granted priority review by USFDA for muscle-invasive bladder cancer
Do Not Issue Licenses Without New Drug Permission from DCGI, Govt Panel Tells StatesAlprazolam tablets worth Rs one crore seized, 2 arrested
Drug Safety Alert: IPC Flags Adverse Reactions to Amphotericin B and CarbimazoleDrug Safety Alert: IPC Flags Adverse Reactions to Amphotericin B and Carbimazole
Dr Reddys Secures CDSCO Panel Approval to Import, Market Olutasidenib for AMLKazakhstan authority levies Rs 28.7 lakh penalty on Dr Reddy's Labs unit
Unlicensed Doctor Blamed for Patient’s Death in IndoreFIR Against Aurobindo Pharma Official, Others for Alleged Rs 3,600 Crore Share Acquisition Scam
X